{"result": "(\"entity\"<|>PHENYLKETONURIA<|>EVENT<|>Phenylketonuria is a metabolic disorder that requires dietary management and is discussed in various medical literature and guidelines.)\n##\n(\"entity\"<|>HYPERPHENYLALANINEMIA<|>EVENT<|>Hyperphenylalaninemia is a condition related to phenylketonuria, often addressed in medical research and treatment protocols.)\n##\n(\"entity\"<|>CYSTATHIONINE BETA-SYNTHASE<|>ORGANIZATION<|>Cystathionine beta-synthase is an enzyme whose structure and function are studied in relation to homocystinuria.)\n##\n(\"entity\"<|>GLYCOGEN STORAGE DISEASE<|>EVENT<|>Glycogen storage disease refers to a group of inherited metabolic disorders that affect glycogen metabolism, discussed in various medical guidelines.)\n##\n(\"entity\"<|>SODIUM PHENYLBUTYRATE<|>EVENT<|>Sodium phenylbutyrate is a treatment used for urea cycle disorders, as mentioned in medical literature.)\n##\n(\"entity\"<|>BRANCHED-CHAIN AMINO ACIDS<|>EVENT<|>Branched-chain amino acids are a group of amino acids that are relevant in the context of metabolic disorders and their treatment.)\n##\n(\"entity\"<|>Urea Cycle Disorders<|>EVENT<|>Urea cycle disorders are a group of genetic conditions that affect the body's ability to remove ammonia, discussed in medical literature.)\n##\n(\"entity\"<|>HOMOCYSTINURIA<|>EVENT<|>Homocystinuria is a genetic disorder that affects the metabolism of homocysteine, often covered in medical research.)\n##\n(\"entity\"<|>METABOLIC DISEASES<|>EVENT<|>Metabolic diseases encompass a range of disorders that affect metabolism, frequently discussed in medical guidelines and literature.)\n##\n(\"entity\"<|>NUTRITIONAL TREATMENT<|>EVENT<|>Nutritional treatment is a key aspect of managing metabolic disorders, as highlighted in various medical publications.)\n##\n(\"entity\"<|>DIAGNOSTIC PROTOCOL<|>EVENT<|>Diagnostic protocols are established guidelines for identifying metabolic disorders, as referenced in medical literature.)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ; 2013\n8.   Bibliografía                                                       15.   Fenilcetonuria-        Nutricia      (Internet).     Nutricia.\n1.   Campistol J, Lambruschini V, Gómez L, Gutierrez S,                       es.2016. Available from: http://www.nutricia.es/\n     Fusté R, Villaseca B. Hiperfenilalaninemia. En San-                      areas-terapeuticas/fenilcetonuria-pku/\n     jurjo P, Baldellou A (ed). Diagnóstico y tratamiento               16.   Wappner RS, Gibson KM. Disorders of leucine me-\n     de las Enfermedades Metabólicas Hereditarias.3ª                          tabolism. En: Blau N, Hoffmann GF, Leonard J,\n     ed. Madrid, Ergon 2009. p. 423-440                                       Clarke JJR (eds). Physician’s guide to the treatment\n2.   Donlon J, Levy H, Scriver CR, Hyperphenylalanine-                        and follow-up of metabolic diseases.Berlín: Sprin-\n     mia. Phenylalanine hydroxylase deficiency.The me-                        ger-Verlag; 2006. p. 59-79\n     tabolic and molecular bases of inherited disease.                  17.   Dalmau      Serra    J,  Fernández       Sánchez     A,   Sán-\n     McGraw Hill; Chapter 77, 2008                                            chez-Valverde Visus F, Vitoria Miñana I. Enferme-\n3.   Desviat LR, Pérez B, García MJ, Martinez-Pardo M,                        dad de orina de jarabe de arce. En Sanjurjo P, Bal-\n     Baldellou A, Arena J,        et al. Relationship between                 dellou A (ed). Diagnóstico y tratamiento de las\n     mutation genotype and biochemical phenotype in a                         Enfermedades         Metabólicas       Hereditarias.3ª      ed.\n     heterogeneous        Spanish     phenylketonuria       popula-           Madrid, Ergon 2009. p. 489-498\n     tion.Eur J Hum Genet 1997; 5: 196-202.                             18.   Ruiz Pons M, Sánchez-Valverde Visus F, Dalmau\n4.   Smith I, Beasley MG, Ades AE. Intelligence and qua-                      Serra J, Gómez López L. Tratamiento nutricional\n     lity of dietary treatment in phenylketonuria.Arch Dis                    de los errores innatos del metabolismo. 2ª ed; 4:\n     Child 1990; 65: 472-8.                                                   175-194.\n---\n                                              Tema 18.      Soporte nutricional en metabolopatías de los aminoácidos…                  321\n\n\n\n19.  Santer R, Harnacke K, Burlina A. MSUD-From diet                           do 28/9/2012. Consultado 7/1/2017. www.omim.\n     to liver transplantation. EMG Workshop Procce-                            org/entry/232200\n     dings , Freiburg, 2016.                                             30.   Moreno Villares JM; Manzanares López-Manzana-\n20.  Burrage LC, Jain M, Gandolfo L, Lee BH. Sodium                            res J; Díaz Fernández MC; Benlloch Marín T. Proto-\n     phenylbutyrate decreases plasma branched-chain                            colo de diagnóstico y seguimiento de pacientes\n     amino acids in patients with urea cycle disorders.                        con glucogenosis de afectación fundamentalmen-\n     Genet Metab 2014; 113 (1-2):131-5.                                        te hepática. Glucogenosis. Madrid. 2011.\n21.  Miles   EW,    Kraus    JP.  Cystathionine     b-synthase:          31.   Koeberl D, Kishnani P, Chen Y. Glycogen storage\n     Structure, Function, Regulation, and Location of                          disease types I and II: Treatment updates. J Inherit\n     Homocystinuria causing Mutations. Journal of Bio-                         Metab Dis. 2007; 30(2): 159–164. Disponible en:\n     logical Chemistry 2004; 279 (29): 29871-29874.                            http://www.ncbi.nlm.nih.gov/pmc/articles/\n22.  Kniffin CL. Homocystinuria due to cystathionine                           PMC2692363/\n     beta-synthase deficiency. OMIM© – Online Men-                       32.   Chou J, Jun H, Mansfield B. Neutropenia in type Ib\n     delian      Inheritance        in     Man©.Actualizado                    glycogen      storage     disease.     CurrOpinHematol.\n     10/11/2010.Consultado          7/1/2017.      www.omim.                   2010; 17(1): 36–42. Disponible en: http://www.\n     org/entry/36200                                                           ncbi.nlm.nih.gov/pmc/articles/PMC3099242/\n23.  Picker JD, Levy HL. Homocystinuria caused by cys-                   33.   Banka S, Newman W. A clinical and molecular re\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIA<|>ORGANIZATION<|>Nutricia is a company that provides nutritional support and resources for metabolic disorders, including phenylketonuria.)\n##\n(\"entity\"<|>SANJURJO P<|>PERSON<|>Sanjurjo P is an editor of a comprehensive guide on the diagnosis and treatment of hereditary metabolic diseases.)\n##\n(\"entity\"<|>ERGO<|>ORGANIZATION<|>Ergon is a publishing house that published the 3rd edition of the guide on hereditary metabolic diseases.)\n##\n(\"entity\"<|>FREIBURG<|>GEO<|>Freiburg is a city in Germany where the EMG Workshop Proceedings were held in 2016.)\n##\n(\"entity\"<|>OMIM<|>ORGANIZATION<|>OMIM (Online Mendelian Inheritance in Man) is a comprehensive, authoritative compendium of human genes and genetic disorders.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital city of Spain, where several publications and guidelines related to metabolic diseases were published.)\n##\n(\"entity\"<|>JOURNAL OF BIOLOGICAL CHEMISTRY<|>ORGANIZATION<|>The Journal of Biological Chemistry publishes research articles on the biochemical and molecular basis of biological processes.)\n##\n(\"entity\"<|>EMG WORKSHOP<|>EVENT<|>The EMG Workshop is an event focused on metabolic disorders, where professionals gather to discuss advancements and treatments.)\n##\n(\"relationship\"<|>NUTRICIA<|>SANJURJO P<|>Sanjurjo P edited a guide that includes information on Nutricia's contributions to metabolic disease treatment<|>7)\n##\n(\"relationship\"<|>ERGO<|>SANJURJO P<|>Ergon published the guide edited by Sanjurjo P on metabolic diseases<|>6)\n##\n(\"relationship\"<|>MADRID<|>ERGO<|>Ergon is based in Madrid, where it published the guide on hereditary metabolic diseases<|>5)\n##\n(\"relationship\"<|>FREIBURG<|>EMG WORKSHOP<|>The EMG Workshop was held in Freiburg, focusing on metabolic disorders<|>8)\n##\n(\"relationship\"<|>OMIM<|>JOURNAL OF BIOLOGICAL CHEMISTRY<|>OMIM provides genetic information that is often referenced in research published in the Journal of Biological Chemistry<|>4)\n<|COMPLETE|>"}]}